Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dermata Therapeutics, Inc. (DRMA) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dermata Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1853816.
Total stock buying since 2021: $97,630.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 208,571 | $97,630 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-11 | 20,000 | $48,000 | 0 | $0 | 0 | $0 |
| 2021-08 | 188,571 | $49,630 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-23 | Proehl Gerald T (President, CEO and Chairman) | Buy | 20,000 | 2.40 | 48,000 |
| 2021-08-17 | Proehl Gerald T (President, CEO and Chairman) | Buy | 142,857 | .00 | 0 |
| 2021-08-17 | Hale David F | Buy | 35,714 | .00 | 0 |
| 2021-08-16 | Proehl Gerald T (President, CEO and Chairman) | Buy | 10,000 | 4.96 | 49,630 |
Insider trading activities including stock purchases, stock sales, and option exercises of DRMA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dermata Therapeutics, Inc. (symbol DRMA, CIK number 1853816) see the Securities and Exchange Commission (SEC) website.